Hidden Quality Behind Temporary Headwinds
Rating: BUY
Target Price: 232 SEK
Upside: +23,4%
Getinge is a high-quality global medtech company trading at a discount, despite its strong recurring revenue base, resilient profitability, and leading market positions across critical healthcare infrastructure. As regulatory overhangs gradually resolve and margin pressure from tariffs and currency headwinds fades, the company is positioned for a multi-year earnings recovery supported by recurring consumables, digital health solutions, and improving operational leverage.
Analyst: Johan Ström
01/04/2026